Nicolas Garreau de Loubresse

Nicolas Garreau de Loubresse is a seasoned professional in the life sciences sector with extensive experience in business development, partnerships, and advisory roles. Currently serving as the Head of Business Development & Partnerships at Biostate AI, Nicolas leads initiatives to develop AI for predicting health changes and drug outcomes. As the Founder and Managing Director of MS2, a life science advisory firm, Nicolas offers expertise in product management and commercial strategy. Previous positions include Vice President of Business Development at Culmination Bio, where Nicolas facilitated the use of real-world data for therapeutic development, and Head of Business Development at NuProbe, an oncology genomics company. Nicolas also co-founded Urania Therapeutics, leveraging ribosome technologies for drug design, and held roles at Harvard Medical School as a Business Development Fellow and Research Fellow in Systems Biology. Nicolas earned a Ph.D. in Molecular and Cell Biology from the University of Strasbourg.